drugset / Trial / NCT03327285
C-CAR011 Treatment in Subjects With ALL After HSCT
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, prospective clinical study evaluating safety and efficacy of C-CAR011 treatment in subjects with ALL after HSCT
Timeline
- Start
- 2018-03-01
- Primary completion
- 2021-02-28
- Completion
- 2021-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | C-CAR011 | Cell therapy | 1e+06 cells/kg | — |
| Subject | C-CAR011 | Cell therapy | 5e+06 cells/kg | — |